Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus

• Eará dahkkit: Sjöwall, Christopher (Doaimmaheaddji), Parodis, Ioannis (Doaimmaheaddji)
• Materiálatiipa: Elektrovnnalaš Girjji oassi
• Giella: eaŋgalasgiella
• Almmustuhtton: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Fáttát: Medicine; systemic lupus erythematosus; quality of life; cross-sectional studies; surveys and questionnaires; rheumatoid arthritis; fatigue; pain; psychosocial; disease activity; health-related quality of life; patient-reported outcomes; clinical follow-up; outcome measures; abnormal liver function tests; autoimmune liver diseases; autoimmune hepatitis; hepatic involvement; liver biopsy; primary biliary cholangitis; COVID-19; hydroxychloroquine; glucocorticoids; epidemiology; Systemic Lupus Erythematosus; outcome; mortality; survival; end-stage renal disease; cancer; cardiovascular disease; infections; neoplasm; hospital admissions; medication adherence; compliance; patient perspective; qualitative research; classification; cluster analysis; laboratory; linear discriminant analysis; genetics; chronic damage; polymorphisms; TNFSF4; MIR1279; Ki/SL; proteasome; autoantibodies; lupus; SLE; Sjögren syndrome; flare; damage; long disease duration; trajectories; remission; low disease activity; comorbidities; mood disorders; low-disease activity; patient outcome; Afro-Caribbean; systemic lupus; lupus nephritis; long-term prognosis; dehydroepiandrosterone; SLEDAI-2K; n/a
• Liŋkkat: DOAB: download the publication; DOAB: description of the publication

The clinical spectrum of systemic lupus erythematosus (SLE) is highly heterogeneous, ranging from mild disease, which can be limited to skin and joint involvement, to life-threatening conditions with renal impairment, severe cytopenias, central nervous system disease, and thromboembolic events. Apar...